Cargando…
The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis
Ciji-Hua’ai-Baosheng II Formula (CHB-II-F) is a traditional Chinese medical formula that has been shown in clinical practice to relieve side effects of chemotherapy and improve quality of life for cancer patients. In order to understand the mechanism of its protective effects on chemotherapy, mice w...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331466/ https://www.ncbi.nlm.nih.gov/pubmed/30670974 http://dx.doi.org/10.3389/fphar.2018.01539 |
_version_ | 1783387137137180672 |
---|---|
author | Fu, Biqian Xi, Shengyan Wang, Yanhui Zhai, Xiangyang Wang, Yanan Gong, Yuewen Xu, Yangxinzi Yang, Jiaqi Qiu, Yingkun Wang, Jing Lu, Dawei Huang, Shuqiong |
author_facet | Fu, Biqian Xi, Shengyan Wang, Yanhui Zhai, Xiangyang Wang, Yanan Gong, Yuewen Xu, Yangxinzi Yang, Jiaqi Qiu, Yingkun Wang, Jing Lu, Dawei Huang, Shuqiong |
author_sort | Fu, Biqian |
collection | PubMed |
description | Ciji-Hua’ai-Baosheng II Formula (CHB-II-F) is a traditional Chinese medical formula that has been shown in clinical practice to relieve side effects of chemotherapy and improve quality of life for cancer patients. In order to understand the mechanism of its protective effects on chemotherapy, mice with transplanted H(22) hepatocellular carcinoma were employed in this study. Ninety-two mice were injected subcutaneously with H(22) HCC cell suspension into the right anterior armpit. After mice were treated with 5-fluorine pyrimidine (5-FU), they were divided into six groups as untreated group, 5-FU group, 5-FU plus Yangzheng Xiaoji Capsule group and three groups of 5-FU plus different concentrations of CHB-II-F. Twenty mice were euthanized after 7 days of treatment in untreated and medium concentration of CHB-II-F groups and all other mice were euthanized after 14 days of treatment. Herbal components/metabolites were analyzed by UPLC-MS. Tumors were evaluated by weight and volume, morphology of light and electron microscope, and cell cycle. Apoptosis were examined by apoptotic proteins expression by western blot. Four major components/metabolites were identified from serum of mice treated with CHB-II-F and they are β-Sitosterol, Salvianolic acid, isobavachalcone, and bakuchiol. Treatment of CHB-II-F significantly increased body weights of mice and decreased tumor volume compared to untreated group. Moreover, CHB-II-F treatment increased tumor cells in G(0)-G(1) transition instead of in S phase. Furthermore, CHB-II-F treatment increased the expression of pro-apoptotic proteins and decreased the expression anti-apoptotic protein. Therefore, CHB-II-F could improve mice general condition and reduce tumor cell malignancy. Moreover, CHB-II-F regulates apoptosis of tumor cells, which could contribute its protective effect on chemotherapy. |
format | Online Article Text |
id | pubmed-6331466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63314662019-01-22 The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis Fu, Biqian Xi, Shengyan Wang, Yanhui Zhai, Xiangyang Wang, Yanan Gong, Yuewen Xu, Yangxinzi Yang, Jiaqi Qiu, Yingkun Wang, Jing Lu, Dawei Huang, Shuqiong Front Pharmacol Pharmacology Ciji-Hua’ai-Baosheng II Formula (CHB-II-F) is a traditional Chinese medical formula that has been shown in clinical practice to relieve side effects of chemotherapy and improve quality of life for cancer patients. In order to understand the mechanism of its protective effects on chemotherapy, mice with transplanted H(22) hepatocellular carcinoma were employed in this study. Ninety-two mice were injected subcutaneously with H(22) HCC cell suspension into the right anterior armpit. After mice were treated with 5-fluorine pyrimidine (5-FU), they were divided into six groups as untreated group, 5-FU group, 5-FU plus Yangzheng Xiaoji Capsule group and three groups of 5-FU plus different concentrations of CHB-II-F. Twenty mice were euthanized after 7 days of treatment in untreated and medium concentration of CHB-II-F groups and all other mice were euthanized after 14 days of treatment. Herbal components/metabolites were analyzed by UPLC-MS. Tumors were evaluated by weight and volume, morphology of light and electron microscope, and cell cycle. Apoptosis were examined by apoptotic proteins expression by western blot. Four major components/metabolites were identified from serum of mice treated with CHB-II-F and they are β-Sitosterol, Salvianolic acid, isobavachalcone, and bakuchiol. Treatment of CHB-II-F significantly increased body weights of mice and decreased tumor volume compared to untreated group. Moreover, CHB-II-F treatment increased tumor cells in G(0)-G(1) transition instead of in S phase. Furthermore, CHB-II-F treatment increased the expression of pro-apoptotic proteins and decreased the expression anti-apoptotic protein. Therefore, CHB-II-F could improve mice general condition and reduce tumor cell malignancy. Moreover, CHB-II-F regulates apoptosis of tumor cells, which could contribute its protective effect on chemotherapy. Frontiers Media S.A. 2019-01-08 /pmc/articles/PMC6331466/ /pubmed/30670974 http://dx.doi.org/10.3389/fphar.2018.01539 Text en Copyright © 2019 Fu, Xi, Wang, Zhai, Wang, Gong, Xu, Yang, Qiu, Wang, Lu and Huang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Fu, Biqian Xi, Shengyan Wang, Yanhui Zhai, Xiangyang Wang, Yanan Gong, Yuewen Xu, Yangxinzi Yang, Jiaqi Qiu, Yingkun Wang, Jing Lu, Dawei Huang, Shuqiong The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis |
title | The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis |
title_full | The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis |
title_fullStr | The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis |
title_full_unstemmed | The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis |
title_short | The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis |
title_sort | protective effects of ciji-hua’ai-baosheng ii formula on chemotherapy-treated h(22) hepatocellular carcinoma mouse model by promoting tumor apoptosis |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331466/ https://www.ncbi.nlm.nih.gov/pubmed/30670974 http://dx.doi.org/10.3389/fphar.2018.01539 |
work_keys_str_mv | AT fubiqian theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT xishengyan theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT wangyanhui theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT zhaixiangyang theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT wangyanan theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT gongyuewen theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT xuyangxinzi theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yangjiaqi theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT qiuyingkun theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT wangjing theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT ludawei theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT huangshuqiong theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT fubiqian protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT xishengyan protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT wangyanhui protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT zhaixiangyang protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT wangyanan protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT gongyuewen protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT xuyangxinzi protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yangjiaqi protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT qiuyingkun protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT wangjing protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT ludawei protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT huangshuqiong protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis |